Literature DB >> 23844936

Perturbation of the indigenous rat oral microbiome by ciprofloxacin dosing.

P Manrique1, M O Freire, C Chen, H H Zadeh, M Young, P Suci.   

Abstract

Mucosal surfaces such as the gut, vagina and oral cavity are colonized by microbiota that are an integral component of the healthy ecosystem. Recent molecular techniques make it feasible to correlate antimicrobial dosing levels with changes in microbiome composition. The objective of this study was to characterize the rat oral plaque microbiome composition at doses of ciprofloxacin that were considerably above and below nominal in vitro minimal inhibitory concentrations of a variety of gram-positive oral commensal bacteria. We exposed the oral cavities of rats to relatively low (0.1 μg ml(-1) ) and high (20 μg ml(-1)) doses of ciprofloxacin in the drinking water over a 3-day period. Plaque microbiota were characterized using 454 pyrosequencing. The rat indigenous community was dominated by the genera Rothia (74.4%) and Streptococcus (4.7%). Dosing at 0.1 μg ml(-1) was associated with changes in Rothia and Streptococcus species that were not significant, whereas dosing at 20 μg ml(-1) caused a pronounced (significant) reduction in the relative abundance of the Streptococcus genus. Taxonomic independent analysis indicated that the perturbation in the overall community structure attributed to dosing with ciprofloxacin at either the low or high dose was relatively low. The results suggest that it is feasible to use an antimicrobial dosing regimen to selectively target a specific subset of a mucosal microbiome for elimination with minimal perturbation of the entire community.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ciprofloxacin; microbiome; oral; periodontitis; rat

Mesh:

Substances:

Year:  2013        PMID: 23844936      PMCID: PMC3767763          DOI: 10.1111/omi.12033

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  51 in total

1.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

2.  Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates.

Authors:  J A Hoogkamp-Korstanje; J Roelofs-Willemse
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

3.  Aggregatibacter actinomycetemcomitans-induced bone loss and antibody response in three rat strains.

Authors:  Helen Schreiner; Kenneth Markowitz; Manjula Miryalkar; Danielle Moore; Scott Diehl; Daniel H Fine
Journal:  J Periodontol       Date:  2010-08-03       Impact factor: 6.993

Review 4.  Human microbiome in health and disease.

Authors:  Kathryn J Pflughoeft; James Versalovic
Journal:  Annu Rev Pathol       Date:  2011-09-09       Impact factor: 23.472

Review 5.  The fluoroquinolone antibacterials: past, present and future perspectives.

Authors:  P C Appelbaum; P A Hunter
Journal:  Int J Antimicrob Agents       Date:  2000-09       Impact factor: 5.283

6.  AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.

Authors:  Nibras A Ahmed; Fernanda C Petersen; Anne A Scheie
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

7.  Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.

Authors:  Gema del Prado; Vicente Ruiz; Plinio Naves; Violeta Rodríguez-Cerrato; Francisco Soriano; María del Carmen Ponte
Journal:  Diagn Microbiol Infect Dis       Date:  2010-08       Impact factor: 2.803

8.  Microbial ecology of plaque in rats with naturally occurring gingivitis.

Authors:  E Isogai; H Isogai; H Sawada; H Kaneko; N Ito
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

9.  The canine oral microbiome.

Authors:  Floyd E Dewhirst; Erin A Klein; Emily C Thompson; Jessica M Blanton; Tsute Chen; Lisa Milella; Catherine M F Buckley; Ian J Davis; Marie-Lousie Bennett; Zoe V Marshall-Jones
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Defining the healthy "core microbiome" of oral microbial communities.

Authors:  Egija Zaura; Bart J F Keijser; Susan M Huse; Wim Crielaard
Journal:  BMC Microbiol       Date:  2009-12-15       Impact factor: 3.605

View more
  5 in total

1.  Deficiency of BrpA in Streptococcus mutans reduces virulence in rat caries model.

Authors:  Zezhang T Wen; Kathleen Scott-Anne; Sumei Liao; Arpan De; Meng Luo; Christopher Kovacs; Brendaliz S Narvaez; Roberta C Faustoferri; Qingzhao Yu; Christopher M Taylor; Robert G Quivey
Journal:  Mol Oral Microbiol       Date:  2018-07-17       Impact factor: 3.563

2.  Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.

Authors:  Parish P Sedghizadeh; Shuting Sun; Adam F Junka; Eric Richard; Keivan Sadrerafi; Susan Mahabady; Neema Bakhshalian; Natalia Tjokro; Marzenna Bartoszewicz; Monika Oleksy; Patrycja Szymczyk; Mark W Lundy; Jeffrey D Neighbors; R Graham G Russell; Charles E McKenna; Frank H Ebetino
Journal:  J Med Chem       Date:  2017-02-13       Impact factor: 7.446

3.  Ligature-associated bacterial profiles are linked to type 2 diabetes mellitus in a rat model and influenced by antibody treatment against TNF-α or RAGE.

Authors:  M B Grauballe; D Belstrøm; J A Østergaard; B J Paster; S Schou; A Flyvbjerg; P Holmstrup
Journal:  Clin Exp Dent Res       Date:  2017-02-27

4.  A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats With Porphyromonas gingivalis Induced Periodontal Disease.

Authors:  Molly S Walkenhorst; Leticia Reyes; Gonzalo Perez; Ann Progulske-Fox; Mary B Brown; Priscilla L Phillips
Journal:  Front Cell Infect Microbiol       Date:  2020-03-06       Impact factor: 5.293

5.  Microbiome-Metabolome Signature of Acute Kidney Injury.

Authors:  Nadezda V Andrianova; Vasily A Popkov; Natalia S Klimenko; Alexander V Tyakht; Galina V Baydakova; Olga Y Frolova; Ljubava D Zorova; Irina B Pevzner; Dmitry B Zorov; Egor Y Plotnikov
Journal:  Metabolites       Date:  2020-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.